Ginkgo Bioworks Holdings, Inc.

Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), sponsored by Eagle Equity Partners and led by Harry Sloan, Jeff Sagansky, and Eli Baker, completed its initial public offering in February 2021, targeting technology and life sciences opportunities. The blank-check company filed a Form 10-Q on August 16, 2021, covering the quarterly period ended June 30, 2021, at which point its planned business combination with synthetic biology platform company Ginkgo Bioworks had been announced but was pending close. That merger subsequently closed in September 2021, with the combined entity listing on the New York Stock Exchange under the ticker symbol DNA. For comprehensive filing history and deal analytics on SRNG, sign up for full access at SpacDesk.